Overview

CD ComputaBio is a leading bioinformatics company specializing in providing cutting-edge services and solutions in the field of structure-activity relationship (SAR) research. Our dedicated team of experienced scientists and bioinformatics experts is committed to optimizing drug discovery efforts by elucidating the complex relationships between a compound's structure and its biological activity. With advanced algorithms, innovative methodologies, and state-of-the-art tools, CD ComputaBio empowers researchers and pharmaceutical companies to make informed decisions, streamline the drug development process, and maximize success.

Our Services

SAR Analysis and Prediction

We provide in-depth SAR analysis services utilizing advanced computational methods to identify key structure-activity relationships.
Our team performs comprehensive analyses of structural features, fragment contributions, and physicochemical properties to reveal key insights into target compound interactions.
We employ a suite of cutting-edge algorithms to predict and optimize compound properties such as binding affinity, selectivity, and drug similarity.

SAR Modeling and Virtual Screening

CD ComputaBio specializes in SAR modeling and builds powerful predictive models using various machine learning and statistical methods.
We utilize state-of-the-art virtual screening tools to accelerate the identification of potential drug candidates from large compound libraries.
Our in-house designed SAR database facilitates the building of customized models, saving time and resources for drug development efforts.

Applications

Drug Discovery and Design

CD ComputaBio helps clients effectively identify promising drug candidates and optimize their structures based on SAR studies.
We can understand and predict the activity, toxicity profile, and therapeutic potential of compounds.

ADME-Tox Optimization

Our SAR services provide valuable insights into the absorption, distribution, metabolism, excretion, and toxicity (ADME-Tox) properties of compounds.
By analyzing the structure-activity relationship, we help clients optimize drug molecules to enhance their pharmacokinetic and safety profiles.

Algorithm

CD ComputaBio employs advanced quantitative structure-activity relationship (QSAR) modeling techniques to predict compound activities based on their chemical structures.
We utilize machine learning algorithms, such as random forest, support vector machines, and deep learning, coupled with feature selection and cross-validation methods.

Sample Requirements

Sample Requirements	Descriptions
Molecular structures	Molecular structures in standard formats (e.g. SDF, PDB, or MOL files)
Detailed biological activity data	Detailed biological activity data, including known activities, IC50, EC50, Ki, or pIC50 values
Supporting information	Additional relevant compound information (e.g. ADMET data, toxicology profiles, or intended therapeutic target)

Deliverables

Sample Requirements	Descriptions
Comprehensive SAR Analysis Reports:	Summary of SAR findings, highlighting the critical factors influencing compound activity Detailed analysis of physicochemical properties, fragment contributions, and molecular interactions Visualization of SAR relationships, including activity cliffs and structure-activity landscapes
Accurate Predictive Models:	QSAR models encompassing various performance metrics, such as R2, Q2, and predictive accuracy Predictions of compound activities, including compound ranking and prioritization for further experimental validation

Why Choose Us?

CD ComputaBio's Structure-Activity Relationship services offer comprehensive solutions to propel drug discovery programs towards success. By leveraging advanced algorithms and cutting-edge methodologies, we assist clients in unraveling the complex relationship between compound structures and their biological activities. Contact us today to learn more about our service information.

For research use only. Not intended for any clinical use.

SAR Service